Published in PLoS One on July 27, 2017
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res (2003) 5.30
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res (1999) 4.68
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res (2007) 4.53
c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature (2014) 3.78
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem (2007) 3.53
Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J (1993) 3.43
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol (2007) 3.33
Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol (2006) 3.24
Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res (2003) 3.16
cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol (1992) 2.91
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med (2008) 2.68
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell (2007) 2.05
TGFBI gene mutations in corneal dystrophies. Hum Mutat (2006) 2.01
Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am J Pathol (2005) 1.76
Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication. PLoS One (2012) 1.68
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair (2012) 1.65
Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem (2009) 1.57
Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci (2011) 1.54
TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta. Int J Biochem Cell Biol (2007) 1.51
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch (2011) 1.49
The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci (2013) 1.42
Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res (2011) 1.41
Revisiting Cardiac Cellular Composition. Circ Res (2015) 1.38
Periostin family of proteins: therapeutic targets for heart disease. Anat Rec A Discov Mol Cell Evol Biol (2005) 1.35
Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway. Proc Natl Acad Sci U S A (2012) 1.23
Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol (2014) 1.13
Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome. J Biol Chem (2009) 1.10
Periostin shows increased evolutionary plasticity in its alternatively spliced region. BMC Evol Biol (2010) 1.06
BigH3 protein expression as a marker for breast cancer. Int J Mol Med (2008) 0.98
Release of TGFβig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression. Carcinogenesis (2012) 0.97
A mouse model of chronic idiopathic pulmonary fibrosis. Physiol Rep (2014) 0.96
Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun (2016) 0.96
Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol (2013) 0.96
Pathological ventricular remodeling: therapies: part 2 of 2. Circulation (2013) 0.90
Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice. Circ Res (2016) 0.87
TGFBI protein high expression predicts poor prognosis in colorectal cancer patients. Int J Clin Exp Pathol (2015) 0.85
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients. Br J Cancer (2014) 0.83
Periostin and TGF-β-induced protein: Two peas in a pod? Crit Rev Biochem Mol Biol (2015) 0.82
Pathogenesis and treatments of TGFBI corneal dystrophies. Prog Retin Eye Res (2015) 0.81
STIM1 elevation in the heart results in aberrant Ca(2+) handling and cardiomyopathy. J Mol Cell Cardiol (2015) 0.81
Initial Suppression of Transforming Growth Factor-β Signaling and Loss of TGFBI Causes Early Alveolar Structural Defects Resulting in Bronchopulmonary Dysplasia. Am J Pathol (2016) 0.79
Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling. Arterioscler Thromb Vasc Biol (2015) 0.79
Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan. BMC Cardiovasc Disord (2015) 0.75
Thrombospondin expression in myofibers stabilizes muscle membranes. Elife (2016) 0.75